CD4 and neoplasm: The accumulation of Treg at tumor sites may be due to the concomitant or the preferential occurrence of distinct events, such as the recruitment of Treg from periphery, the proliferation of pre-existing Treg in the tumor microenvironment, and the de novo conversion of tumor-infiltrating CD4+ lymphocytes (TIL) into pTreg (14, 15).